Outcomes of metastatic breast cancer patients in relationship to disease‐free interval following primary treatment of localized disease; a pooled analysis of two clinical trials-Reference-Cited by-同舟云学术

Outcomes of metastatic breast cancer patients in relationship to disease‐free interval following primary treatment of localized disease; a pooled analysis of two clinical trials

Published:2019-05-27 Issue:5 Volume:25 Page:823-828
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Abdel‐Rahman Omar¹²^ORCID

Affiliation:

1. Clinical Oncology Department, Faculty of Medicine Ain Shams University Cairo Egypt

2. Tom Baker Cancer Centre, Department of Oncology University of Calgary Calgary Alberta Canada

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.13346

Reference21 articles.

1. globocan.iarc.fr. Last Accessed On 27/11/2016.

2. Breast cancer diagnosis and mortality by tumor stage and migration background in a nationwide cohort study in Sweden

3. Defining the illness trajectory of metastatic breast cancer

4. M-bioscore: proposing a new statistical model for prognostic factors in metastatic breast cancer patients

5. Metastatic breast cancer: are we treating the same patients as in the past?

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival and prognostic factors in oligometastatic breast cancer;The Breast;2023-02

2. Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta‐analysis;International Journal of Cancer;2022-10-24

3. Clinical outcomes and metastatic behavior between de novo versus recurrent HER2-positive metastatic breast cancer;Journal of the Chinese Medical Association;2021-09-20

4. Clinical Features and Serological Markers Risk Model Predicts Overall Survival in Patients Undergoing Breast Cancer and Bone Metastasis Surgeries;Frontiers in Oncology;2021-09-17

5. A systematic literature review of prognostic factors in patients with HR+/HER2− advanced breast cancer in Japan;Japanese Journal of Clinical Oncology;2021-08-21